Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
IDRI Makes Its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
June 24th, 2009
Following the World Health Organization (WHO) declaration of swine flu pandemic, the Infectious Disease Research Institute (IDRI) announced it has successfully developed an adjuvant that could significantly enhance both the effectiveness and supplies of pandemic flu vaccines. The Seattle-based not-for-profit organization will make its adjuvant technology available to flu vaccine manufacturers for the production of A (H1N1) or future pandemic flu vaccines. "As stressed by Dr. Chan at today's press conference, there is a real urgency to address the needs of developing countries for adequate supplies of swine flu pandemic vaccines. She rightly urged for global solidarity...
Source: Vaccine Weekly (2009-06-24)
|